Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $30,174 | 1 | 98.0% |
| Food and Beverage | $613.85 | 9 | 2.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $30,174 | 1 | $0 (2022) |
| Novo Nordisk Inc | $357.13 | 3 | $0 (2022) |
| Gilead Sciences, Inc. | $127.08 | 1 | $0 (2024) |
| ABIOMED | $47.96 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $43.05 | 2 | $0 (2022) |
| Organon LLC | $27.05 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $11.58 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.08 | 1 | Gilead Sciences, Inc. ($127.08) |
| 2022 | $30,417 | 6 | Eli Lilly and Company ($30,174) |
| 2021 | $243.73 | 3 | Novo Nordisk Inc ($232.15) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $127.08 | General |
| Category: HBV | ||||||
| 08/03/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $47.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/26/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: VACCINES | ||||||
| 04/13/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Diabetes | ||||||
| 04/07/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: VACCINES | ||||||
| 03/23/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: ETONOGESTREL | ||||||
| 01/14/2022 | Eli Lilly and Company | — | — | Cash or cash equivalent | $30,174.00 | Research |
| 09/22/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $107.17 | General |
| Category: Diabetes | ||||||
| 06/16/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Diabetes | ||||||
| 04/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 183 | 341 | $31,480 | $14,670 |
| 2022 | 17 | 487 | 3,278 | $136,522 | $67,064 |
| 2021 | 15 | 429 | 3,908 | $147,360 | $83,842 |
| 2020 | 10 | 237 | 3,364 | $107,800 | $64,156 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 70 | $9,150 | $4,162 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,500 | $3,312 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 27 | $4,860 | $2,715 | 55.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 22 | 38 | $4,640 | $2,658 | 57.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $2,730 | $1,014 | 37.2% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 17 | 18 | $2,160 | $712.08 | 33.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 144 | $1,440 | $96.37 | 6.7% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2022 | 18 | 2,052 | $40,790 | $21,712 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $10,750 | $4,920 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 64 | $8,212 | $4,412 | 53.7% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2022 | 45 | 198 | $9,900 | $4,112 | 41.5% |
| 97530 | Therapy procedure using functional activities | Office | 2022 | 33 | 137 | $6,850 | $4,093 | 59.7% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 45 | 198 | $9,900 | $3,559 | 36.0% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2022 | 42 | 46 | $4,600 | $3,296 | 71.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 19 | 59 | $7,000 | $3,220 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 34 | $6,120 | $3,133 | 51.2% |
| 76881 | Complete ultrasound scan of joint | Office | 2022 | 45 | 64 | $7,680 | $2,981 | 38.8% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2022 | 35 | 142 | $7,100 | $2,622 | 36.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 17 | 27 | $3,720 | $2,431 | 65.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 13 | 13 | $4,550 | $2,383 | 52.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 13 | 26 | $3,900 | $2,219 | 56.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,950 | $1,209 | 62.0% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2022 | 11 | 47 | $2,350 | $662.39 | 28.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 23 | 115 | $1,150 | $97.90 | 8.5% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2021 | 15 | 2,677 | $53,540 | $36,123 | 67.5% |
About Dr. Xin Wang, MD
Dr. Xin Wang, MD is a Physical Medicine & Rehabilitation healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124004783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xin Wang, MD has received a total of $30,788 in payments from pharmaceutical and medical device companies, with $127.08 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "" ($30,174).
As a Medicare-enrolled provider, Wang has provided services to 1,336 Medicare beneficiaries, totaling 10,891 services with total Medicare billing of $229,733. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Houston, TX
- Active Since 12/15/2005
- Last Updated 02/07/2018
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1124004783
Products in Payments
- Ozempic (Drug) $232.15
- Vemlidy (Drug) $127.08
- RYBELSUS (Drug) $124.98
- Impella (Device) $47.96
- SHINGRIX (Biological) $43.05
- NEXPLANON (Drug) $27.05
- FARXIGA (Drug) $11.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Houston
Dr. Gerard Francisco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $556,498
Dr. Suzanne Manzi, M.d., Faapmr, M.D., FAAPMR
Physical Medicine & Rehabilitation — Payments: $195,379
Cindy Ivanhoe, Md, MD
Physical Medicine & Rehabilitation — Payments: $158,583
Gunjan Patel, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $153,260
Sheng Li, Md, Phd, MD, PHD
Physical Medicine & Rehabilitation — Payments: $38,565
Ankur Mehta, Do, DO
Physical Medicine & Rehabilitation — Payments: $30,036